The deal involved two legs: Vinci issued a cash-settled convertible bond and simultaneously bought OTC call options to hedge ...

The possibilities for material design and production of plastic components are being expanded through 3D printing technology. However, there is a shortage of recyclable polymers that meet the ...

Tom Equels, CEO of AIM ImmunoTech and Professor Casper H.J. van Eijck, MD, PhD, Pancreato-biliary Surgeon at Erasmus MC, discuss the Phase 1b/2 clinical trial involving AIM's Ampligen® (rintatolimod) ...

THIS PRESS RELEASE MAY NOT BE PUBLISHED, DISTRIBUTED OR DISSEMINATED, DIRECTLY OR INDIRECTLY, IN THE UNITED STATES OF AMERICA, AUSTRALIA, CANADA, SOUTH AFRICA OR JAPAN. This press release does not ...

VINCI announces the launch of a €375 million offering (which may be increased to €400 million) of non-dilutive cash-settled ...